Lv4
480 积分 2024-09-25 加入
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
2天前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
9天前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
9天前
已完结
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
15天前
已完结
Tumor cells upregulate neurotransmitter GABA in the choroid plexus through STAT6-Bestrophin1 signaling, promoting leptomeningeal dissemination
21天前
已完结
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
22天前
已完结
Intrathecal Sintilimab for Leptomeningeal Metastases of Non-small Cell Lung Cancer Failed from Targeted Therapy and Intrathecal Chemotherapy (LMIS study)
23天前
已完结
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
2个月前
已完结
The Proposed 9th Edition TNM Classification of Lung Cancer
2个月前
已完结
Real-World Evidence Supporting the Consensus-Driven DILI Control Compounds List: An Analysis of FAERS Data
3个月前
已完结
皖公网安备34019202002308
